Biotech Values

[masterlongevity]

$NVS WHat program are they planning to take into Phase 3 for AD.? The CAD-106 vaccine program did not look good as they didnt produce good titres in a large % of pts. If thats going forward, then JnJ/Pfe should definitely push ACC-001 forward. It actually looked quite good, but JnJ/PFE seem to be in a complete holding pattern on AD, despite equal or lesser drugs moving forward